Authors: NAVIA MA TUNG RD CHATURVEDI PR RAO BG PARTALEDIS JA KIM EE

Citation: Ma. Navia et al., STRUCTURE-BASED DRUG DESIGN OF HIV PROTEASE INHIBITORS, The FASEB journal, 10(6), 1996, pp. 2436-2436

Authors: LIVINGSTON DJ PAZHANISAMY S PARTALEDIS JA TUNG RD

Citation: Dj. Livingston et al., RELEVANCE OF PLASMA-PROTEIN BINDING TO ANTIVIRAL ACTIVITY AND CLINICAL EFFICACY OF INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE - REPLY, The Journal of infectious diseases, 173(6), 1996, pp. 1525-1526

Authors: PARTALEDIS JA YAMAGUCHI K TISDALE M BLAIR EE FALCIONE C MASCHERA B MYERS RE PAZHANISAMY S FUTER O CULLINAN AB STUVER CM BYRN RA LIVINGSTON DJ

Citation: Ja. Partaledis et al., IN-VITRO SELECTION AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ISOLATES WITH REDUCED SENSITIVITY TO HYDROXYETHYLAMINO SULFONAMIDE INHIBITORS OF HIV-1 ASPARTYL PROTEASE, Journal of virology, 69(9), 1995, pp. 5228-5235

Authors: LIVINGSTON DJ PAZHANISAMY S PORTER DJT PARTALEDIS JA TUNG RD PAINTER GR

Citation: Dj. Livingston et al., WEAK BINDING OF VX-478 TO HUMAN PLASMA-PROTEINS AND IMPLICATIONS FOR ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS THERAPY, The Journal of infectious diseases, 172(5), 1995, pp. 1238-1245

Authors: PARTALEDIS JA BERLIN V

Citation: Ja. Partaledis et V. Berlin, THE FKB2 GENE OF SACCHAROMYCES-CEREVISIAE, ENCODING THE IMMUNOSUPPRESSANT-BINDING PROTEIN FKBP-13, IS REGULATED IN RESPONSE TO ACCUMULATIONOF UNFOLDED PROTEINS IN THE ENDOPLASMIC-RETICULUM, Proceedings of the National Academy of Sciences of the United Statesof America, 90(12), 1993, pp. 5450-5454